sign up for news
search site
donate now

Dear Chancellor of the Exchequer and Secretary of State for Health and Social Care

Re: One Cancer Voice charities call for clarity on workforce funding announced in the Spending Review

We are following up our letter of 8th October to seek clarity and assurance that the announcement in the Spending Review: “The government will provide hundreds of millions of pounds in additional funding over the SR21 period to ensure a bigger and better trained NHS workforce” will meet the needs of people affected by cancer enabling the Government to deliver on its commitments on cancer diagnosis, survival and care.

We recognise and welcome commitments in the Spending Review, notably the additional investment to tackle the backlog and the capital investment for Community Diagnostic Centres which will play a critical role in improving diagnosis of cancer. However, we fear this investment will not deliver the desired outcome if it is not mirrored by an accompanying increase in staffing levels to deliver these services. We therefore seek urgent clarity on the level of funding that Health Education England will receive and how additional investment will be targeted.

In our previous correspondence we asked that you:

• Deliver on the Government’s manifesto pledge to plan for the cancer workforce by providing a multi-year settlement to train and employ more cancer staff to fill current vacancies and ensure that the workforce has the capacity to meet increasing demand, innovate and drive lifesaving research. Around £200m additional investment in Health Education England is needed over the 3 years to grow the key cancer professions by 45% by 2029.
• Create a Cancer Nurse Fund of £124 million to train the next generation of Cancer Nurse Specialists, helping to deliver on the NHS Long-Term Plan promise for every patient to get a named cancer nurse.

In response to the Parliamentary Petition to ‘Invest urgently in the NHS cancer workforce in the autumn Spending Review,’ the Government said: “Allocations and profiles will be confirmed as part of the Spending Review, which will set out the Government’s spending plans for health and social care for future years, including the NHS Workforce.”

We were therefore concerned that this detail was absent in the Spending Review announcement and associated documents.
Much depends on this funding.

You will be aware that our ask for investment in the cancer workforce reflects commitments in the NHS People Plan which states: “when the government further clarifies the available budget to expand the workforce and make sure that education and training is fit for the future – as expected to be set out in the forthcoming spending review – more details will follow.” We are keen to understand when more information will be made available and how we can support and inform that process.

You will be aware that there is widespread support for this investment in the NHS and cancer workforce. It is recognised by the Health and Social Care Select Committee through its cancer services inquiry, that a number of All Party Parliamentary Groups have jointly petitioned Government on this issue, and it is also backed by the public polling from Ipsos MORI which recently revealed the ‘biggest problems facing Britain’s healthcare system’ was not enough staff.

We want to support the Department and Health Education England in addressing this challenge. Long term investment in the cancer workforce is critical to clearing the cancer backlog in time, meeting early diagnosis targets and improving how we provide care. Without this action, to meet demand for diagnosis and care, patients will suffer and good investments announced last week will fail to deliver.

We look forward to your reply.

Yours Sincerely

Tina Seymour
Hope For Tomorrow

Jeannie Rigby
Chief Executive
Action Bladder Cancer UK

Will Jones
Chief Executive
Brains Trust

Jane Lyons
Chief Executive
Cancer 52

Michelle Mitchell OBE
Chief Executive
Cancer Research UK

Natalie Haskell

Samantha Dixon
Chief Executive
Jo’s Cervical Cancer Trust

Zack Pemberton-Whiteley
Chief Executive
Leukaemia Care

Lynda Thomas
Chief Executive
Macmillan Cancer Support

Gillian Nuttall
Chief Executive
Melanoma UK

Tony Heddon
Neuroblastoma UK

Diana Jupp
Chief Executive
Pancreatic Cancer UK

Richard Davidson
Chief Executive
Sarcoma UK

Annwen Jones OBE
Chief Executive
Target Ovarian Cancer

Athena Lamnisos
Chief Executive
The Eve Appeal

Kathryn Scott
Chief Executive
Yorkshire Cancer Research

Rachel Kirby- Rider
Young Lives vs Cancer

Nick Turkentine
Chief Operating Officer
Kidney Cancer UK

Henny Braund
Chief Executive
Anthony Nolan

Baroness Delyth Morgan
Chief Executive
Breast Cancer Now

Genevieve Edwards
Chief Executive
Bowel Cancer UK

Robin Pritchard
Cancer Care Map

Ashley Gamble
Chief Executive
Children’s Cancer and Leukaemia Group

Colleen Shaw
Chief Executive
Friends of the Cancer Centre

Rose Woodward
Founder and Patient Advocate
Kidney Cancer Support Network

Fiona Hazel
Chief Executive
Leukaemia UK

Liz Darlison MBE
Chief Executive Officer
Mesothelioma UK

Victoria Clare

Angela Culhane
Chief Executive
Prostate Cancer UK

Gail Jackson
Chief Executive
Solving Children’s Cancer

Kate Collins
Chief Executive
Teenage Cancer Trust

Seren Hughes
Head of Engagement

Professor Frank Chinegwundoh MBE
Cancer Black Care

Sarahjane Robertson
Chief Executive
Look Good Feel Better

Gemma Peters
Chief Executive
Blood Cancer UK

Pamela Healy OBE
Chief Executive
British Liver Trust

Sue Farrington Smith MBE
Chief Executive
Brain Tumour Research

John Symons
Cancer of Unknown Primary Foundation – Jo’s friends

Marc Auckland
CLLSA Chair of Trustees
CLL Support Association

Dr Jen Kelly
Grace Kelly Childhood Cancer Trust

Anna Jewell
Less Survivable Cancers Taskforce

Ropinder Gill
Chief Executive
Lymphoma Action

Sarah McDonald
Director of Research
Myeloma UK

Cary Wakefield
Ovarian Cancer Action

Mike Grundy
Deputy Chief Executive
Roy Castle Lung Cancer Foundation

Ken Mastris
Tackle Prostate Cancer

Dr David Jenkinson
Chief Executive
The Brain Tumour Charity

Rachael Gormley
World Cancer Research Fund

Samantha Dixon
Chief Executive
Jo’s Cervical Cancer Trust

Nina Barough CBE
Chief Executive
Walk the Walk Worldwide

Share this:

Sign up for news

Sign up for news so that we can share updates on our work and how your support is making a difference.